Skip to main navigation Skip to search Skip to main content

Quantitative PCR analysis for Bcl-2/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma.

Translated title of the contribution: Quantitative PCR analysis for Bcl-2/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma.
  • L. Goff
  • , K. Summers
  • , S. Iqbal
  • , J. Kuhlmann
  • , M. Kunz
  • , T. Louton
  • , A. Hagenbeek
  • , F. Morschhauser
  • , B. Putz
  • , A. Lister
  • , A. Rohatiner

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionQuantitative PCR analysis for Bcl-2/IgH in a phase III study of Yttrium-90 Ibritumomab Tiuxetan as consolidation of first remission in patients with follicular lymphoma.
Original languageUndefined/Unknown
Pages (from-to)6094-6100
Number of pages7
JournalJournal of Clinical Oncology
Volume27
Issue number36
Publication statusPublished - 2009

Cite this